SCHEMBL29537119

SCHEMBL29537119

CSc1ncc2cc(Oc3ccc(F)cc3F)c(=O)[nH]c2n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 10/20 0.57
▸ MAPK8 P45983 9/20 0.44
▸ MET P08581 1/20 0.42
▸ TRPA1 O75762 3/20 0.41
▸ RPS6KA4 O75676 2/20 0.40
▸ MAPK9 P45984 2/20 0.40
▸ RPS6KA3 P51812 2/20 0.40
▸ MAPK10 P53779 2/20 0.40
▸ MAPK11 Q15759 2/20 0.40
▸ NLK Q9UBE8 2/20 0.40
▸ CSNK1E P49674 1/20 0.40
▸ GAK O14976 1/20 0.39
▸ PRKD3 O94806 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CSNK1D P48730 1/20 0.39
▸ DDR1 Q08345 1/20 0.39
▸ TAOK1 Q7L7X3 1/20 0.39
▸ COQ8A Q8NI60 1/20 0.39
▸ PRKD2 Q9BZL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13239748 1.00 MAPK14 (0.57) MAPK14MAPK8METTRPA1RPS6KA4
SCHEMBL29537130 0.85 BRD4 (0.45) MAPK14MET
SCHEMBL25228119 0.85 BRD4 (0.45) MAPK14MET
SCHEMBL30640268 0.84 MAPK14 (0.41) MAPK14METMAPK1
SCHEMBL22139066 0.82 MAPK14 (0.60) MAPK14MAPK8TRPA1RPS6KA4MAPK9
SCHEMBL29593402 0.82 MAPK14 (0.52) MAPK14MAPK8MAPK1
SCHEMBL14266291 0.81 MAPK14 (0.56) MAPK14MAPK8TRPA1MAPK9MAPK10
SCHEMBL6073545 0.77 HPGD (0.40) MAPK14MAPK1
SCHEMBL14014098 0.76 MAPK14 (0.70) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL29830087 0.76 MAPK14 (0.70) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112079830-B Inhibitor containing fused ring derivative, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-12-22 — — CN disclosed
CN-116710453-A Kinase inhibitors and uses thereof 璧辰医药技术股份有限公司 2023-09-05 — — CN disclosed
EP-4192582-A1 KINASE INHIBITORS AND USES THEREOF ABM Therapeutics Corporation (US) 2023-06-14 — — EP disclosed
CN-115322193-A EGFR and/or HER2 inhibitors and methods of use 达纳-法伯癌症研究所股份有限公司 2022-11-11 — — CN disclosed
CN-111032655-B EGFR and/or HER2 inhibitors and methods of use 达纳-法伯癌症研究所股份有限公司 2022-09-02 — — CN disclosed
WO-2022032071-A1 KINASE INHIBITORS AND USES THEREOF ABM THERAPEUTICS CORPORATION (US) 2022-02-10 — — WO disclosed
Send feedback